238 related articles for article (PubMed ID: 9754765)
1. Bilateral non-familial renal cell carcinoma.
Grimaldi G; Reuter V; Russo P
Ann Surg Oncol; 1998 Sep; 5(6):548-52. PubMed ID: 9754765
[TBL] [Abstract][Full Text] [Related]
2. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML
Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
[TBL] [Abstract][Full Text] [Related]
3. Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes.
Pahernik S; Cudovic D; Roos F; Melchior SW; Thüroff JW
BJU Int; 2007 Jul; 100(1):26-9. PubMed ID: 17552949
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience.
Klatte T; Wunderlich H; Patard JJ; Kleid MD; Lam JS; Junker K; Schubert J; Böhm M; Allhoff EP; Kabbinavar FF; Crepel M; Cindolo L; De La Taille A; Tostain J; Mejean A; Soulie M; Bellec L; Bernhard JC; Ferriere JM; Pfister C; Albouy B; Colombel M; Zisman A; Belldegrun AS; Pantuck AJ
BJU Int; 2007 Jul; 100(1):21-5. PubMed ID: 17433034
[TBL] [Abstract][Full Text] [Related]
5. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
Blute ML; Itano NB; Cheville JC; Weaver AL; Lohse CM; Zincke H
J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
[TBL] [Abstract][Full Text] [Related]
6. Prognosis and characteristics of renal cell carcinoma in hemodialysis patients: bilateral occurrence does not influence cancer-specific survival.
Takagi T; Kondo T; Izuka J; Kobayashi H; Tomita E; Hashimoto Y; Tanabe K
Int J Urol; 2011 Dec; 18(12):806-12. PubMed ID: 21917022
[TBL] [Abstract][Full Text] [Related]
7. The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses.
Boorjian SA; Crispen PL; Lohse CM; Leibovich BC; Blute ML
Eur Urol; 2008 Oct; 54(4):855-63. PubMed ID: 18487007
[TBL] [Abstract][Full Text] [Related]
8. Validation of a Postoperative Nomogram Predicting Recurrence in Patients with Conventional Clear Cell Renal Cell Carcinoma.
Lee BH; Feifer A; Feuerstein MA; Benfante NE; Kou L; Yu C; Kattan MW; Russo P
Eur Urol Focus; 2018 Jan; 4(1):100-105. PubMed ID: 28753780
[TBL] [Abstract][Full Text] [Related]
9. [Bilateral kidney tumor. Therapy management and histopathological results with long-term follow-up of 66 patients].
Siemer S; Uder M; Zell A; Pönicke C; Humke U; Ziegler M; Stöckle M
Urologe A; 2001 Mar; 40(2):114-20. PubMed ID: 11315585
[TBL] [Abstract][Full Text] [Related]
10. Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma.
Beck SD; Patel MI; Snyder ME; Kattan MW; Motzer RJ; Reuter VE; Russo P
Ann Surg Oncol; 2004 Jan; 11(1):71-7. PubMed ID: 14699037
[TBL] [Abstract][Full Text] [Related]
11. Precancerous lesions in the kidney.
Van Poppel H; Nilsson S; Algaba F; Bergerheim U; Dal Cin P; Fleming S; Hellsten S; Kirkali Z; Klotz L; Lindblad P; Ljungberg B; Mulders P; Roskams T; Ross RK; Walker C; Wersäll P
Scand J Urol Nephrol Suppl; 2000; (205):136-65. PubMed ID: 11144893
[TBL] [Abstract][Full Text] [Related]
12. The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment.
Bhindi B; Thompson RH; Lohse CM; Mason RJ; Frank I; Costello BA; Potretzke AM; Hartman RP; Potretzke TA; Boorjian SA; Cheville JC; Leibovich BC
Eur Urol; 2018 Oct; 74(4):489-497. PubMed ID: 30017400
[TBL] [Abstract][Full Text] [Related]
13. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease.
Blute ML; Amling CL; Bryant SC; Zincke H
Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous radiofrequency ablation for renal cell carcinoma vs. partial nephrectomy: Comparison of long-term oncologic outcomes in both clear cell and non-clear cell of the most common subtype.
Liu N; Huang D; Cheng X; Chong Y; Wang W; Gan W; Guo H
Urol Oncol; 2017 Aug; 35(8):530.e1-530.e6. PubMed ID: 28408296
[TBL] [Abstract][Full Text] [Related]
15. Multiple Discordant Histology After Nephrectomy: Descriptive Analysis and Outcomes.
Harlow BL; Klaassen Z; Holzman S; Reinstatler L; Franken AA; Kavuri SK; Terris MK; Master VA; Moses KA
Clin Genitourin Cancer; 2016 Apr; 14(2):e171-5. PubMed ID: 26613833
[TBL] [Abstract][Full Text] [Related]
16. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
[TBL] [Abstract][Full Text] [Related]
17. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications.
Haferkamp A; Kurosch M; Pritsch M; Hatiboglu G; Macher-Goeppinger S; Pfitzenmaier J; Pahernik S; Wagener N; Hohenfellner M
Ann Surg Oncol; 2010 Feb; 17(2):544-51. PubMed ID: 19953334
[TBL] [Abstract][Full Text] [Related]
19. Renal cell carcinoma in young patients is associated with poorer prognosis.
Lee LS; Yuen JS; Sim HG
Ann Acad Med Singap; 2011 Sep; 40(9):401-6. PubMed ID: 22065033
[TBL] [Abstract][Full Text] [Related]
20. Synchronous Bilateral RCC Is Associated With Poor Recurrence-Free Survival Compared With Unilateral RCC: A Single-Center Study With Propensity Score Matching Analysis.
Kim JK; Lee H; Oh JJ; Lee S; Hong SK; Lee SE; Byun SS
Clin Genitourin Cancer; 2019 Jun; 17(3):e570-e580. PubMed ID: 30922860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
